Impact of inhaled corticosteroids on asthma hospitalization in Sweden

Applied Economics

Volumn 28, Issue 12, 1996, Pages 1591-1599

  Gerdtham, Ulf G ^a   Hertzman, Peter ^b   Boman, Gunnar ^c   Jönsson, Bengt ^a  

^a STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000590560     PISSN: 00036846     EISSN: None     Source Type: Journal    
DOI: 10.1080/000368496327561     Document Type: Article

References (30)

1. Balestra, P. and Nerlove, M. (1966) Pooling cross section and time series data in the estimation of a dynamic model: the demand for natural gas, Econometrica, 34, 585-612.
2. Barnes, P. J. (1989) A new approach to the treatment of asthma, New England Journal of Medicine, 321, 1517-1527.
3. Bolton, M. B., Tilley, B. C., Kuder, J., Reeves, T. and Schulz, L. R. (1991) The cost and effectiveness of an education program for adults who have asthma, J. Gen. Intern. Med, 6, 401-407.
4. Boman, G. (1991) Epidemiology of obstructive lung disease in the Nordic countries, European Respiratory Review, 1, 316-320.
5. British Thoracic Society (1993) Guidelines for the management of asthma, Thorax, 48, Supplement, 1-24.
6. Brogden, R. and McTavish, D. (1992) Budesonide. An updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis, Drugs, 3, 375-407.
7. Burney, P., Papacosta, A., Whitey, J., Colley, J. and Holland, W. (1991) Hospital and admission rates and the prevalence of asthma symptoms in 20 local authority districts, Thorax, 46, 574-579.
8. Davidson, R. and Mackinnon, J. (1981) Several tests for model specification in the presence of multiple alternatives, Econometrica, 49, 781-793.
9. Federation of County Councils (1993) Kostnader per intagen patient, värddag, läkarbesök mm (cost per discharge, bed-day, outpatient visit), Federation of County Councils, Stockholm.
10. Fisher, E. S., Wennberg, J. E., Stukel, T. A. and Sharp, S. M. (1994) Hospital readmission rates for cohorts of medicare beneficiaries in Boston and New Haven, New England Journal of Medicine, 331, 989-995.
11. Gerdtham, U-G., Hertzman, P., Boman, G., and Jönsson, B. (1993) Impact of inhaled corticosteroids on asthma hospitalization in Sweden: A pooled regression analysis, EFI Research Report Nr 91, Stockholm School of Economics.
12. Greene, W. H. (1991) User's Manual and Reference Guide, version 6.0, Econometric Software Inc (Australia).
13. Hausmaa, J. (1978) Specification tests in econometrics, Econometrica, 46, 626-632.
14. Hay, I. and Higgingham, T.W. (1987) Has the management of asthma improved?, Lancet, 12, 609-611.
15. International Asthma Management Project (1992) International consensus report on diagnosis and management of asthma, Allergy, 47, Supp 13.
16. Larsson, L., Boethius, G. and Uddenfeldt, M. (1994) Differences in utilization of asthma drugs between two neighbouring Swedish provinces, relation to prevalence of obstructive airway disease, Thorax, 49, 41-49.
17. Läkemedelsstatistik AB (1991) Medical Index Sweden, Stockholm: Läkemedelsstatistik AM.
18. Maddala, G. S. (1971) The use of variance components models in pooling cross-section and time-series data, Econometrica, 39, 341-358.
19. National Board of Health and Welfare (1991) Socialstyrelsens patientregister över sluten somatisk vård 1964-1983. En kvalitetsstudie, SoS-rapport 1991-20, National Board of Health and Welfare, Stockholm.
20. National Board of Health and Welfare (1992) Kvaliteten i Socialstyrelsens slutenvårdsregister för 1986, Epidemiologiskt centrum, Folkhälsoenheten (mimeo).
21. National Corporation of Swedish Pharmacies, Sales statistics, various years.
22. Nerlove, M. (1971) A note on error components models, Econometrica, 39, 383-396.
23. Nordenstam, I., Wennberg, M. and Kristoferson, K. (1992) Swedish drug statistics 91, Apoteksbolaget, Stockholm.
24. Otulana, B. A., Varma, N., Bullock, A. and Higenbottom, T. (1992) High dose nebulized steroid in the treatment of chronic steroid-dependent asthma, Respiratory Medicine, 86, 105-8.
25. Rutten-van Mölken et al. (1995) Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 151, 975-982.
26. Selroos, O. (1991) The effects of inhaled corticosteroids on the natural history of obstructive lung diseases, Eur Respir Rev, 1. 354-365.
27. Weiss, K. P., Gergen, P. and Hodgson, T. (1992) An economic evaluation of asthma in the United States, The New England Journal of Medicine, 326, 862-866.
28. Wessling, A. (1990) The national prescription survey, A data base for drug utilization studies in Sweden: results and experiences from the 1970s and 1980s. Thesis, Department of Clinical Pharmacology of the Karolinska Institute, Huddinge University Hospital.
29. Åberg, N. (1988) Asthma and allergic rhinitis in Swedish conscripts. Thesis, Faculty of Medicine, Gothenburg University.
30. Ädelroth, E., and Thompson, S. (1988) Advantages of high-dose inhaled budesonide, Lancet, ii, 476.